| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.07 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.27 | 0.07 |